QUEBEC, Jan. 7 /CNW Telbec/ - Mr. Benoit Côte, President and Chief
Executive Officer of Biotanika Inc. ("Biotanika") and Mr. Will McCamy,
co-founder and President of Xymogen are proud to announce that dolorox(TM),
artriphen(TM) and coolsens(TM), a line of products developed by Biotanika to
manage pain related problems and prevent musculoskeletal pathologies, will be
launched on the US Health Care Practitioner market in February 2009. This
natural base line of products is supported with pre-clinical and clinical
Xymogen, an American company headquartered in Orlando, Florida, a member
of the 2007 500 fastest growing companies agreed to distribute and co-brand
Biotanika products to its thousands of nationwide clients including doctors,
naturopaths and health care practitioners. "Our new collaboration and
partnership with Biotanika has allowed us to build upon the principles of
safety and efficiency and take our scope of service and expertise to another
level. The new Biotanika formulas that we are releasing in 2009 mark a
significant chapter in the evolution of our company", says Mr. Will McCamy.
The products developed by Biotanika will be a leading line for Xymogen
and Biotanika intends to introduce a new product for pain management in this
market segment every year.
Xymogen and Biotanika agreed to commercialize their products under the
brand Xymogen E P-Professional Line by Biotanika. "For Biotanika, it is
crucial to build a reliable and credible brand focusing on efficacy and safety
for consumers. "We feel that the Xymogen / Biotanika relationship, if
leveraged properly offers incredible potential for one of the largest, most
compelling markets in the health sciences arena, pain management. Moving
forward, this convergence of the pharmaceutical/nutraceutical model is the
most exciting, fastest growing segment of the dietary supplement space and one
that both companies can capitalize on for benefits on many levels", conclude
Mr. Côte and Mr. McCamy.
Biotanika Product Line
dolorox(TM): a patent pending combination of various active ingredients
with clinically proven efficacy. Developed to manage acute pain, dolorox(TM)
provides fast relief for arthritis and osteoarthritis pain, morning stiffness
and lower back pain.
artriphen(TM): a patent pending combination of various active ingredients
with clinically proven efficacy. artriphen(TM) helps develop and maintain
healthy cartilage, prevents pain associated with osteoarthritis, and improves
joint mobility and functionality.
coolsens(TM): a gel combining various active ingredients with clinically
proven efficacy. coolsens(TM) provides relief for muscle pain, relaxes muscles
before and after daily physical activity and relieves heavy legs. coolsens(TM)
is salycilate free and safe for use with blood thinners.
Biotanika develops and markets natural health products, whose efficacy
has been demonstrated, providing an alternative to prescription drugs for
people suffering from pathologies that affect their quality of life.
Biotanika experienced team has an extensive background in the
pharmaceutical industry and is specialized in preclinical, clinical and
regulatory development of drugs and natural health products, as well as in
marketing and retailing.
For further information:
For further information: Benoit Côte, President and Chief Executive
Officer, Biotanika Inc., (418) 653-3423, ext. 1701, firstname.lastname@example.org,